{
    "clinical_study": {
        "@rank": "25342", 
        "arm_group": [
            {
                "arm_group_label": "Arm 1", 
                "arm_group_type": "Experimental", 
                "description": "Sequence A: Gemcitabine 300 mg/m2/week plus radiation therapy (RT)"
            }, 
            {
                "arm_group_label": "Arm 2", 
                "arm_group_type": "Experimental", 
                "description": "Sequence B: Gemcitabine 300 mg/m2/week plus paclitaxel 30 mg/m2/week and RT"
            }, 
            {
                "arm_group_label": "Arm 3", 
                "arm_group_type": "Experimental", 
                "description": "Sequence A: Gemcitabine 300 mg/m2/week plus carboplatin 2 AUC and RT"
            }, 
            {
                "arm_group_label": "Arm 4", 
                "arm_group_type": "Experimental", 
                "description": "Sequence B: Gemcitabine 450 mg/m2/week plus paclitaxel 30 mg/m2/week and RT"
            }, 
            {
                "arm_group_label": "Arm 6", 
                "arm_group_type": "Experimental", 
                "description": "Sequence B: Gemcitabine 450 mg/m2/week plus paclitaxel 40 mg/m2/week and RT"
            }, 
            {
                "arm_group_label": "Arm 8", 
                "arm_group_type": "Experimental", 
                "description": "Sequence B: Gemcitabine 600 mg/m2/week plus paclitaxel 40 mg/m2/week and RT"
            }, 
            {
                "arm_group_label": "Arm 10", 
                "arm_group_type": "Experimental", 
                "description": "Sequence B: Gemcitabine 600 mg/m2/week plus paclitaxel 50 mg/m2/week and RT"
            }, 
            {
                "arm_group_label": "Arm 12", 
                "arm_group_type": "Experimental", 
                "description": "Sequence B: Gemcitabine 750 mg/m2/week plus paclitaxel 50 mg/m2/week and RT"
            }, 
            {
                "arm_group_label": "Arm 14", 
                "arm_group_type": "Experimental", 
                "description": "Sequence B: Gemcitabine 900 mg/m2/week plus paclitaxel 50 mg/m2/week and RT"
            }, 
            {
                "arm_group_label": "Arm 5", 
                "arm_group_type": "Experimental", 
                "description": "Sequence A: Gemcitabine 450 mg/m2/week plus carboplatin 2 AUC and RT"
            }, 
            {
                "arm_group_label": "Arm 7", 
                "arm_group_type": "Experimental", 
                "description": "Sequence A: Gemcitabine 600 mg/m2/week plus carboplatin 2 AUC and RT"
            }, 
            {
                "arm_group_label": "Arm 9", 
                "arm_group_type": "Experimental", 
                "description": "Sequence A: Gemcitabine 750 mg/m2/week plus carboplatin 2 AUC and RT"
            }, 
            {
                "arm_group_label": "Arm 11", 
                "arm_group_type": "Experimental", 
                "description": "Sequence A: Gemcitabine 900 mg/m2/week plus carboplatin 2 AUC and RT"
            }
        ], 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy, such as gemcitabine, carboplatin, and paclitaxel,\n      work in different ways to stop tumor cells from dividing so they stop growing or die.\n      Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy\n      with chemotherapy may kill more tumor cells.\n\n      PURPOSE: Phase I trial to study the effectiveness of combining combination chemotherapy with\n      radiation therapy in treating patients who have stage IIIA or stage IIIB non-small cell lung\n      cancer."
        }, 
        "brief_title": "Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer", 
        "completion_date": {
            "#text": "June 2010", 
            "@type": "Actual"
        }, 
        "condition": "Lung Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the maximum tolerated dose (MTD) of gemcitabine when administered with\n           carboplatin and thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin\n           in patients with stage IIIA or IIIB non-small cell lung cancer.\n\n        -  Determine the MTD of gemcitabine and paclitaxel when administered with thoracic\n           radiotherapy followed by adjuvant gemcitabine and carboplatin in these patients.\n\n      OUTLINE: This is a multicenter, dose-escalation study of gemcitabine and paclitaxel.\n      Patients are sequentially assigned to 1 of 3 treatment regimens.\n\n        -  Regimen A: Patients receive gemcitabine IV over 30-60 minutes on days 1, 8, 22, 29, and\n           43 and thoracic radiotherapy daily 5 days a week for 7 weeks beginning on day 1.\n\n        -  Regimen B (closed to accrual as of 5/13/03): Patients receive gemcitabine and thoracic\n           radiotherapy as in regimen A and carboplatin IV over 30 minutes on days 1, 8, 22, 29,\n           and 43.\n\n        -  Regimen C: Patients receive gemcitabine and thoracic radiotherapy as in regimen A and\n           paclitaxel IV over 1 hour on days 1, 8, 22, 29, and 43.\n\n      At 3 weeks after completion of chemoradiotherapy, all patients receive adjuvant gemcitabine\n      IV over 30-60 minutes on days 71, 78, 92, and 99 and carboplatin IV over 30 minutes on days\n      71 and 92.\n\n      The first 6 patients enrolled receive regimen A to determine the safety of the initial dose\n      of gemcitabine. After completion of regimen A, cohorts of 3-6 patients receive escalating\n      doses of gemcitabine in regimen B (closed to accrual as of 5/13/03) until the maximum\n      tolerated dose (MTD) is determined. In a separate sequence, cohorts of 3-6 patients receive\n      alternating escalating doses of gemcitabine and paclitaxel in regimen C until the MTD is\n      determined. The MTD is defined as the dose preceding that at which at least 3 of 6 patients\n      experience dose-limiting toxicity.\n\n      Patients are followed at 3 months, 6 months, every 3 months for 1 year, every 6 months for 2\n      years, and then annually thereafter.\n\n      PROJECTED ACCRUAL: A maximum of 78 patients will be accrued for this study within 29 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically or cytologically confirmed loco-regionally advanced non-small cell\n             lung cancer meeting one of the following staging criteria:\n\n               -  Medically inoperable stage IIIA\n\n               -  Unresectable stage IIIA or IIIB\n\n          -  Measurable disease on three-dimensional planning CT scan\n\n          -  No post-resection intrathoracic tumor recurrence\n\n          -  No pleural effusion on chest x-ray except those occurring after attempted thoracotomy\n             or other invasive thoracic procedure\n\n          -  No evidence of small cell histology\n\n          -  No evidence of hematogenous or distant metastases\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  Not specified\n\n        Performance status:\n\n          -  Zubrod 0-1\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  Platelet count at least 100,000/mm^3\n\n          -  Absolute granulocyte count at least 2,000/mm^3\n\n          -  Hemoglobin at least 8.0 g/dL\n\n        Hepatic:\n\n          -  Bilirubin no greater than 1.5 mg/dL\n\n          -  Serum glutamate oxaloacetate transaminase (SGOT) no greater than 1.5 times upper\n             limit of normal (unless caused by documented benign disease)\n\n        Renal:\n\n          -  Creatinine no greater than 1.5 mg/dL\n\n        Cardiovascular:\n\n          -  No myocardial infarction within the past 6 months\n\n          -  No symptomatic heart disease, including angina, congestive heart failure, or\n             uncontrolled arrhythmia\n\n        Pulmonary:\n\n          -  Forced expiratory volume (FEV)_1 greater than 1,000 mL\n\n        Other:\n\n          -  No other invasive malignancy within the past 3 years except nonmelanoma skin cancer\n\n          -  No weight loss of more than 10% in 3 months prior to diagnosis\n\n          -  Not pregnant or nursing\n\n          -  Negative pregnancy test\n\n          -  Fertile patients must use effective contraception\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  No prior chemotherapy\n\n        Endocrine therapy:\n\n          -  Not specified\n\n        Radiotherapy:\n\n          -  No prior thoracic or neck radiotherapy\n\n        Surgery:\n\n          -  See Disease Characteristics\n\n          -  No prior complete or subtotal tumor resection"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "35", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 6, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00016315", 
            "org_study_id": "RTOG-0017", 
            "secondary_id": [
                "RTOG-L-0017", 
                "CDR0000068622"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Arm 3", 
                    "Arm 5", 
                    "Arm 7", 
                    "Arm 9", 
                    "Arm 11"
                ], 
                "intervention_name": "carboplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Arm 1", 
                    "Arm 2", 
                    "Arm 3", 
                    "Arm 4", 
                    "Arm 6", 
                    "Arm 8", 
                    "Arm 10", 
                    "Arm 12", 
                    "Arm 14", 
                    "Arm 5", 
                    "Arm 7", 
                    "Arm 9", 
                    "Arm 11"
                ], 
                "intervention_name": "gemcitabine hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Arm 2", 
                    "Arm 4", 
                    "Arm 6", 
                    "Arm 8", 
                    "Arm 10", 
                    "Arm 12", 
                    "Arm 14"
                ], 
                "intervention_name": "paclitaxel", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Arm 1", 
                    "Arm 2", 
                    "Arm 3", 
                    "Arm 4", 
                    "Arm 6", 
                    "Arm 8", 
                    "Arm 10", 
                    "Arm 12", 
                    "Arm 14", 
                    "Arm 5", 
                    "Arm 7", 
                    "Arm 9", 
                    "Arm 11"
                ], 
                "intervention_name": "radiation therapy", 
                "intervention_type": "Radiation"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Gemcitabine", 
                "Carboplatin", 
                "Paclitaxel"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "stage IIIA non-small cell lung cancer", 
            "stage IIIB non-small cell lung cancer"
        ], 
        "lastchanged_date": "October 8, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/RTOG-0017"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Oakland", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94609-3305"
                    }, 
                    "name": "CCOP - Bay Area Tumor Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }, 
                    "name": "University of Miami Sylvester Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dubuque", 
                        "country": "United States", 
                        "state": "Iowa", 
                        "zip": "52001"
                    }, 
                    "name": "Wendt Regional Cancer Center of Finley Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Long Branch", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07740-6395"
                    }, 
                    "name": "Monmouth Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Akron", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44304"
                    }, 
                    "name": "Akron City Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salem", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44460"
                    }, 
                    "name": "Cancer Care Center, Incorporated"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Drexel Hill", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19026"
                    }, 
                    "name": "Delaware County Memorial Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "East Stroudsburg", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "18301"
                    }, 
                    "name": "Dale and Frances Hughes Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15219"
                    }, 
                    "name": "Mercy Hospital of Pittsburgh"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37232-5671"
                    }, 
                    "name": "Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Murray", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84107"
                    }, 
                    "name": "Cottonwood Hospital Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ogden", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84403"
                    }, 
                    "name": "McKay-Dee Hospital Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Provo", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84604"
                    }, 
                    "name": "Utah Valley Regional Medical Center - Provo"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint George", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84770"
                    }, 
                    "name": "Dixie Regional Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84143"
                    }, 
                    "name": "LDS Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Danville", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "24541"
                    }, 
                    "name": "Danville Regional Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Crosse", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "54601"
                    }, 
                    "name": "Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53226"
                    }, 
                    "name": "Medical College of Wisconsin Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53295"
                    }, 
                    "name": "Veterans Affairs Medical Center - Milwaukee (Zablocki)"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "13", 
        "official_title": "A Phase I Study of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Radiation Therapy Followed by Adjuvant Chemotherapy for Patients With Favorable Prognosis Inoperable Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)", 
        "overall_official": {
            "affiliation": "Simmons Cancer Center", 
            "last_name": "Hak Choy, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "January 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "To determine the maximum tolerated dose of gemcitabine with carboplatin-based chemotherapy and radiation therapy", 
                "safety_issue": "Yes", 
                "time_frame": "From start of treatment to 90 days"
            }, 
            {
                "measure": "To determine the maximum tolerated dose of gemcitabine with paclitaxel-based chemotherapy and radiation therapy", 
                "safety_issue": "Yes", 
                "time_frame": "From start of treatment to 90 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00016315"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "19096311", 
                "citation": "Choy H, Jain AK, Moughan J, Curran W, Whipple G, Demas WF, Ettinger DS. RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy (\"ping-pong trial\") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer. J Thorac Oncol. 2009 Jan;4(1):80-6."
            }, 
            {
                "citation": "Choy H, Swann S, Curran W, et al.: A phase I trial of gemcitabine, carboplatin or gemcitabine, paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: an RTOG 0017 study. [Abstract] Int J Radiat Oncol Biol Phys 63 (2 Suppl 1): A-70, S42, 2005."
            }, 
            {
                "citation": "Choy H, Swann S, Walter C, et al.: A phase I trial of gemcitabine, carboplatin or gemcitabine, paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: an RTOG study. [Abstract] J Clin Oncol 23 (Suppl 16): A-7103, 646s, 2005."
            }
        ], 
        "source": "Radiation Therapy Oncology Group", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Radiation Therapy Oncology Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2001", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }, 
    "geocoordinates": {
        "Akron City Hospital": "41.081 -81.519", 
        "CCOP - Bay Area Tumor Institute": "37.804 -122.271", 
        "Cancer Care Center, Incorporated": "40.901 -80.857", 
        "Cottonwood Hospital Medical Center": "40.667 -111.888", 
        "Dale and Frances Hughes Cancer Center": "41 -75.181", 
        "Danville Regional Medical Center": "36.586 -79.395", 
        "Delaware County Memorial Hospital": "39.947 -75.292", 
        "Dixie Regional Medical Center": "37.095 -113.578", 
        "Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center": "43.801 -91.24", 
        "LDS Hospital": "40.761 -111.891", 
        "McKay-Dee Hospital Center": "41.223 -111.974", 
        "Medical College of Wisconsin Cancer Center": "43.039 -87.906", 
        "Mercy Hospital of Pittsburgh": "40.441 -79.996", 
        "Monmouth Medical Center": "40.304 -73.992", 
        "University of Miami Sylvester Comprehensive Cancer Center": "25.789 -80.226", 
        "Utah Valley Regional Medical Center - Provo": "40.234 -111.659", 
        "Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center": "36.166 -86.784", 
        "Veterans Affairs Medical Center - Milwaukee (Zablocki)": "43.039 -87.906", 
        "Wendt Regional Cancer Center of Finley Hospital": "42.501 -90.665"
    }
}